Jinhao Medical (832914) Shareholder Reduction Notice: Chairman, General Manager and Concerted Parties Plan to Reduce Holdings by No More Than 1.968 Million Shares, Representing 1.9987% of Total Share Capital

On March 23, 2026, Huizhou Jinhui Medical Technology Co., Ltd. (Stock abbreviation: Jinhui Medical, Stock code: 832914) released a pre-disclosure announcement regarding shareholders’ planned share reduction (re-disclosure). The company’s chairman Wang Min, general manager Wang Fang, and one of the actual controllers acting in concert, Huizhou Jintongsheng Investment Partnership (Limited Partnership) (hereinafter referred to as “Jintongsheng Investment”), plan to reduce their holdings through centralized bidding or block trades, with a total proposed reduction of no more than 1,968,000 shares, accounting for 1.9987% of the company’s total share capital.

Subject of the reduction and shareholding status

According to the announcement, three shareholders are involved in this reduction: Chairman Wang Min, General Manager Wang Fang, and one of the actual controllers acting in concert, Jintongsheng Investment. As of the disclosure date, their shareholdings are as follows:

Details of the reduction plan

According to the announcement, the specific reduction plans for the three shareholders are as follows:

The announcement also states that Jintongsheng Investment, as one of the actual controllers acting in concert, does not include shares indirectly held by the company’s controlling shareholder and actual controller. The reduction involves the controlling shareholder, the substantial controller, and their acting in concert, and during the reduction period, they may sell more than 1% of the company’s total shares through centralized bidding or block trades.

Compliance and impact of the reduction

Jinhui Medical states that this reduction plan does not violate the “Company Law,” “Securities Law,” “Beijing Stock Exchange Stock Listing Rules,” or “Guidelines for Continuous Supervision of Listed Companies on Beijing Stock Exchange No. 8—Share Reduction,” or any other relevant laws and regulations. The reduction involves no other transaction arrangements, will not change the company’s controlling shareholder or actual controller, and will not adversely affect the company’s production and operation. The company has no major negative events or significant risks.

It is noteworthy that the company previously disclosed this reduction plan for the first time in the “Pre-disclosure Announcement of Shareholders’ Proposed Share Reduction” published on March 2, 2026 (Announcement No.: 2026-015). Additionally, relevant shareholders have previously made commitments regarding their shareholding ratio, shareholding amount, holding period, reduction method, reduction quantity, and reduction price. Details can be found in the company’s September 28, 2021, “Initial Public Offering Prospectus,” specifically in the “Section 4: Basic Information of the Issuer” under “Nine Important Commitments.”

Risk reminder

The announcement reminds investors that this reduction plan is driven by shareholders’ own business development or funding needs and carries uncertainties. Shareholders will decide whether and how much to reduce based on market conditions and the company’s stock price, and the quantity and price of reductions are uncertain. There is a risk that the plan may not be fully implemented or only partially executed. The reduction will not lead to a change in the company’s control.

The company advises investors to invest rationally and be aware of investment risks.

Disclaimer: Market risks exist; investments should be cautious. This article is automatically generated by an AI model based on third-party databases and does not represent Sina Finance’s views. All information herein is for reference only and does not constitute personal investment advice. Please refer to the actual announcement for details. For questions, contact biz@staff.sina.com.cn.

Click here to view the original announcement>>